Glioblastoma Clinical Trials in Glendale, AZ

Glioblastoma Clinical Trials in Glendale, AZ

View the best 10 glioblastoma medical studies in Glendale, Arizona. Access promising new therapies by applying to a Glendale-based Glioblastoma clinical trial.

Trials in Glendale, Arizona

Here are the top 9 medical studies for glioblastoma in Glendale, Arizona

Image of Saint Joseph's Hospital and Medical Center in Phoenix, United States.

Bevacizumab

Monoclonal Antibodies

Recruiting1 award
This trial uses DSC-MRI to measure rCBV to determine response to bevacizumab in patients with recurrent glioblastoma. DSC-MRI may help to evaluate changes in cancer blood vessels.
Image of Children's Hospital of Alabama in Birmingham, United States.

Selpercatinib

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 2
This trial will test how well selpercatinib works in treating patients with advanced solid tumors, lymphomas, or histiocytic disorders that have activating RET gene alterations.
Image of Children's Hospital of Alabama in Birmingham, United States.

Tazemetostat

EZH2 Inhibitor

Recruiting1 awardPhase 2
This trial studies how well tazemetostat works in children with certain difficult-to-treat cancers that have specific gene mutations. Tazemetostat is a pill that aims to stop cancer cell growth by blocking a specific protein. The goal is to see if this treatment can help these children when other treatments have failed. Tazemetostat is already approved for treating various cancers, including certain brain tumors in children.
Image of Mayo Clinic-Arizona in Phoenix, United States.

BI 907828 +1 More

MDM2 Inhibitor

Recruiting1 awardPhase 1
This trial tests BI 907828, a new drug for treating brain tumors. It targets adults with newly diagnosed glioblastoma. The drug works by blocking a protein that helps cancer cells grow. The study aims to see how well the drug is absorbed in the tumor and find the highest safe dose when combined with radiation therapy.
Image of Vidant Health in Greenville, United States.

GammaTile radiation therapy implantation +3 More

Brachytherapy

Recruiting3 awardsPhase 4
This trial tests if adding GammaTile radiation therapy to standard treatment can improve outcomes for patients with newly diagnosed GBM. GammaTile delivers quick, direct radiation to the tumor, which may help control the tumor better and improve survival rates.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Temozolomide

Alkylating agents

Recruiting0 awardsPhase 2 & 3
This trial is studying the combination of temozolomide and veliparib compared to temozolomide alone in treating patients with newly diagnosed glioblastoma multiforme.
Image of Mayo Clinic in Arizona in Scottsdale, United States.

WSD0922-FU

EGFR/EGFRvIII Inhibitor

Recruiting1 awardPhase 1
This trial is testing a new drug called WSD0922-FU for patients with aggressive brain and spinal cord cancers. The drug works by blocking a protein that helps cancer cells grow. The goal is to find the best dose and see if it can effectively treat these hard-to-treat cancers.
Image of Children's Hospital of Alabama in Birmingham, United States.

Larotrectinib

Kinase Inhibitor

Recruiting1 awardPhase 2
This trial is testing larotrectinib, which may stop the growth of cancer cells, in patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders that have spread and come back or do not respond to treatment.
Image of Banner MD Anderson in Gilbert, United States.

APL-101

Small Molecule Inhibitor

Recruiting1 awardPhase 2
This trial is testing APL-101, a new drug, on patients with specific genetic changes in their cancer. These patients often don't respond to typical treatments. The drug aims to block a protein that helps cancer cells grow and spread.

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.